AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
53,160,953
Total 13F shares
26,199,923
Share change
+1,568,304
Total reported value
$251,078,561
Put/Call ratio
29%
Price per share
$9.70
Number of holders
137
Value change
+$15,102,389
Number of buys
65
Number of sells
40

Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q3 2021

As of 30 Sep 2021, AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,199,923 shares. The largest 10 holders included BlackRock Inc., ASHFORD CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Elemental Capital Partners LLC, Handelsbanken Fonder AB, NEEDHAM INVESTMENT MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, Senvest Management, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 137 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.